Achillion Pharmaceuticals Inc (ACHN.OQ) Quote| Reuters.com
Edition:
United States

Achillion Pharmaceuticals Inc (ACHN.OQ)

ACHN.OQ on NASDAQ Stock Exchange Global Select Market

8.06USD
24 Jun 2016
Change (% chg)

$-0.65 (-7.46%)
Prev Close
$8.71
Open
$8.10
Day's High
$8.43
Day's Low
$8.04
Volume
521,938
Avg. Vol
414,966
52-wk High
$10.95
52-wk Low
$5.57

ACHN.OQ

Chart for ACHN.OQ

About

Achillion Pharmaceuticals, Inc. is a biopharmaceutical company. The Company's primary business is to discover, develop and commercialize small molecule therapeutics for the treatment of infectious diseases and immune system disorders. The Company is focused on its complement inhibitor platform, directed at advancing small... (more)

Overall

Beta: 2.28
Market Cap(Mil.): $1,101.32
Shares Outstanding(Mil.): 136.64
Dividend: --
Yield (%): --

Financials

  ACHN.OQ Industry Sector
P/E (TTM): -- 38.82 34.11
EPS (TTM): -0.07 -- --
ROI: -1.09 -5.72 14.23
ROE: -1.09 -4.83 15.46

BRIEF-Achillion reports Q1 loss per share $0.13

* Achillion reports first quarter 2016 financial results and provides update on clinical programs

May 03 2016

Competitors

  Price Chg
Pfizer Inc. (PFE.N) $33.97 -0.62
Johnson & Johnson (JNJ.N) $115.63 -1.75
Novartis AG (NOVN.S) CHF75.75 -1.20
Merck & Co., Inc. (MRK.N) $55.88 -1.80
Roche Holding Ltd. (ROG.S) CHF241.00 -5.50
Roche Holding Ltd. (RO.S) CHF246.20 -3.30
Abbott Laboratories (ABT.N) $37.91 -1.72
AstraZeneca plc (AZN.L) 4,031.50p +133.00
GlaxoSmithKline plc (GSK.L) 1,482.00p +53.00
Bristol-Myers Squibb Co (BMY.N) $70.61 -2.03

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : S&P Capital IQ Quantitative Report
$115.00
Provider : Reuters Investment Profile
$20.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : Wright Reports
$75.00
Provider : New Constructs, LLC
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.